Table 1.
Performance of the Panther Fusion SARS‐CoV‐2 assay by specimen types
| Panther Fusion | Consensus result | PPA (95% CI) | NPA (95% CI) | Cohen's kappa value (95% CI) | |
|---|---|---|---|---|---|
| SARS‐CoV‐2 assay | Detected | Not detected | |||
| Nasopharyngeal | |||||
| Detected | 27 | 0 | 96.43% | 100% | 0.97 |
| Not detected | 1 | 32 | (81.65%–99.91%) | (89.11%–100%) | (0.90–1.00) |
| Lower respiratory tract | |||||
| Detected | 28 | 0 | 100% | 100% | 1.00 |
| Not detected | 0 | 11 | (87.66%–100%) | (71.51%–100%) | (1.00–1.00) |
| Deep throat saliva | |||||
| Detected | 24 | 0 | 96.00% | 100% | 0.97 |
| Not detected | 1 | 34 | (79.65%–99.90%) | (89.72%–100%) | (0.90–1.00) |
| Overall sample types | |||||
| Detected | 79 | 0 | 97.53% | 100% | 0.97 |
| Not detected | 2 | 77 | (91.36%–99.70%) | (95.32%–100%) | (0.94–1.00) |
Abbreviations: CI, confidence interval; NPA, negative percent agreement; PPA, positive percent agreement; SARS‐CoV‐2, severe acute respiratory syndrome coronavirus 2.